| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066520 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 03/22/2007 | US20070066518 Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same |
| 03/22/2007 | US20070066515 Novel glycoprotein and pharmaceutical composition containing the same |
| 03/22/2007 | US20070065948 Use of antibody-surrogate antigen systems for detection of analytes |
| 03/22/2007 | US20070065931 use in modulation of gene expression in plant cells; use in optimizing crop traits such as nutritional value, disease resistance, herbicide resistance; agronomics |
| 03/22/2007 | US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B |
| 03/22/2007 | US20070065918 Purified mammalian cytokines; related reagents and methods |
| 03/22/2007 | US20070065917 Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions |
| 03/22/2007 | US20070065916 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065914 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/22/2007 | US20070065913 Isolation of binding proteins with high affinity to ligands |
| 03/22/2007 | US20070065908 antiinflammatories, antiviral agents; coadministering with antibiotic; surface decontamination |
| 03/22/2007 | US20070065906 Process for producing heterologous protein in e. coli |
| 03/22/2007 | US20070065905 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 03/22/2007 | US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels |
| 03/22/2007 | US20070065895 Substrates specific to von willebrand factor cleaving protease and method of assaying the activity |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065881 isolating heterocomplex GM2AP/GM2/MRP14 and mutated GM2AP/GM2/MRP14; gliotoxic |
| 03/22/2007 | US20070065879 Marker for inflammatory conditions |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065849 Nucleic acid encoding eosinophil eotaxin receptor |
| 03/22/2007 | US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 03/22/2007 | US20070065842 Detection of survivin in the biological fluids of cancer patients |
| 03/22/2007 | US20070065829 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto |
| 03/22/2007 | US20070065820 Lipid-associated molecules |
| 03/22/2007 | US20070065819 Novel fprl1 ligands and use thereof |
| 03/22/2007 | US20070065818 encoded by an isolated nucleic acid; a culture product; bioassay for determining the intracellular calcium concentration; immunoassay; bioluminescence resonance energy transfer (BRET) system |
| 03/22/2007 | US20070065810 Diagnosis and treatment of cervical cancer |
| 03/22/2007 | US20070065804 Method for PR-39 peptide mediated selective inhibition of IkappaBalpha degradation |
| 03/22/2007 | US20070065801 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (seotonin) receptor 4 (5-ht4) |
| 03/22/2007 | US20070065514 tumor necrosis factor alpha (TNF alpha ) mutein attached to substrates, to create an adsorbent matrix, that permit binding of immune system inhibitors such as soluble TNF receptors, thereby inducing a vigorous immune response while minimizing toxicity |
| 03/22/2007 | US20070065468 Chimeric allergens for immunotherapy |
| 03/22/2007 | US20070065466 Clostridium difficile vaccine |
| 03/22/2007 | US20070065465 Conjugate vaccines for the prevention of dental caries |
| 03/22/2007 | US20070065464 n immunogenic composition comprising a combination of Streptococcus pyogenes (GAS) antigens in pure form consisting of two to ten GAS antigens including a Spy0269 antigen comprising the amino acid sequence SEQ ID NO:1 and a Spy0416 antigen comprising the amino acid sequence SEQ ID; NO:122.; vaccines |
| 03/22/2007 | US20070065458 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/22/2007 | US20070065457 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/22/2007 | US20070065455 relates to osteopontin (Eta-1) polypeptides ; for enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer; immunization |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065450 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 03/22/2007 | US20070065441 Human PF4A receptors, nucleic acid encoding and antibodies binding thereto |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065430 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 03/22/2007 | US20070065427 Agents that modulate immune cell activation and methods of use thereof |
| 03/22/2007 | US20070065425 Anti-idiotypic antibody neutralizing the inhibitor activity of a factor viii inhibitor antibody |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065409 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 03/22/2007 | US20070065408 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 03/22/2007 | US20070065407 Interferon-Alpha Polypeptides and Conjugates |
| 03/22/2007 | US20070065406 Homogeneous preparations of IL-28 and IL-29 |
| 03/22/2007 | US20070065405 Uses of human Zven proteins and polynucleotides |
| 03/22/2007 | US20070065404 Uses of humans zven proteins and polynucleotides |
| 03/22/2007 | US20070065403 Uses of human Zven proteins and polynucleotides |
| 03/22/2007 | US20070065402 Methods for treating viral infection using il-28 and il-29 |
| 03/22/2007 | US20070065401 Methods for treating viral infection using il-28 and il-29 |
| 03/22/2007 | US20070065398 Photoactivatable composition and uses thereof |
| 03/22/2007 | US20070065362 Gastrin receptor-avid peptide conjugates |
| 03/22/2007 | DE102005043669A1 Verfahren zur enzymatischen Synthese von Ethern A method for the enzymatic synthesis of ethers |
| 03/22/2007 | CA2622827A1 Pharmaceutical compound capable of inducing immune protective response against dengue virus having the capsid protein of the dengue virus |
| 03/22/2007 | CA2622616A1 Collagen receptor i-domain binding modulators |
| 03/22/2007 | CA2622610A1 Fish vaccine |
| 03/22/2007 | CA2622595A1 A material and a method for removing oxo-anions and metal cations from a liquid |
| 03/22/2007 | CA2622587A1 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | CA2622583A1 Rna antagonist compounds for the inhibition of apo-b100 expression |
| 03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
| 03/22/2007 | CA2622525A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 03/22/2007 | CA2621489A1 Plant yield improvement by group 3 lea expression |
| 03/22/2007 | CA2621422A1 Esterase gene and use thereof |
| 03/22/2007 | CA2621344A1 Cleavage of precursors of insulins by a variant of trypsin |
| 03/22/2007 | CA2621337A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 03/22/2007 | CA2621243A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 03/22/2007 | CA2620712A1 Tumor associated antigen isc-468 for diagnosis and therapy |
| 03/22/2007 | CA2618494A1 Process for production of bivalirudin |
| 03/22/2007 | CA2618429A1 A hepatitis c virus non-structural ns3/4a fusion gene |
| 03/22/2007 | CA2602357A1 Branched-chain amino acid aminotransferase gene and use thereof |
| 03/21/2007 | EP1764616A2 Method for identifying apoptosis modified proteins |
| 03/21/2007 | EP1764414A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 03/21/2007 | EP1764413A1 Protein preparation containing s1-5 |
| 03/21/2007 | EP1764412A1 Detection instrument with the use of polynucleotides mapped on barley chromosome |
| 03/21/2007 | EP1764372A1 Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer |
| 03/21/2007 | EP1764371A1 Agonist antibodies that bind to the LT-beta receptor, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764369A1 Vaccines comprising truncated HBC core protein plus saponin-based adjuvant |
| 03/21/2007 | EP1764348A1 A material and a method for removing oxo-anions and metal cations from a liquid |
| 03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
| 03/21/2007 | EP1764109A1 Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764106A2 Use of insulin-like growth factor I for the inhibition of ischemic injury involving the liver |
| 03/21/2007 | EP1763583A2 Plant n-acylethanolamine binding proteins |
| 03/21/2007 | EP1763582A2 Means and methods for controlling flowering in plants |
| 03/21/2007 | EP1763538A2 Genetically engineered cells for therapeutic applications |
| 03/21/2007 | EP1763537A2 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 03/21/2007 | EP1763536A1 Antifungal polypeptides |
| 03/21/2007 | EP1763364A2 Methods and compositions comprising supramolecular constructs |